SCHEMBL25015759

SCHEMBL25015759

NCCCC(=O)Nc1ccc(Cn2c(C(=O)N3CCC(CCN)CC3)cc3ccc(/C(N)=N/O)cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ST14 Q9Y5Y6 11/20 0.39
▸ F10 P00742 9/20 0.39
▸ F2 P00734 8/20 0.39
▸ PLG P00747 7/20 0.39
▸ PLAU P00749 5/20 0.39
▸ HDAC1 Q13547 6/20 0.36
▸ HDAC2 Q92769 6/20 0.36
▸ PRSS1 P07477 4/20 0.36
▸ PRSS2 P07478 2/20 0.36
▸ PRSS3 P35030 2/20 0.36
▸ PTGS2 P35354 1/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC9 Q9UKV0 1/20 0.33
▸ HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016836 0.95 ST14 (0.42) ST14F10F2PLGPLAU
SCHEMBL25016349 0.92 ST14 (0.45) ST14F10F2PLGPLAU
SCHEMBL25016360 0.91 F10 (0.48) ST14F10F2PLGPLAU
SCHEMBL25016835 0.88 ST14 (0.44) ST14F10F2PLGPLAU
SCHEMBL25015872 0.86 F10 (0.51) ST14F10F2PLGPLAU
SCHEMBL25017398 0.84 CCR2 (0.42) ST14F10F2PLGPLAU
SCHEMBL21822210 0.84 CCR2 (0.41) ST14F10F2PRSS1PRSS2
SCHEMBL21822264 0.84 CCR2 (0.41) ST14F10F2PRSS1PRSS2
SCHEMBL25015758 0.83 PTGS2 (0.44) ST14F10F2PRSS1PRSS2
SCHEMBL25017360 0.83 F10 (0.55) ST14F10F2PLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 ST14 150/4885F10 1548/4885F2 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback